clarithromycin "hexal" 500 mg filmovertrukne tabletter
hexal a/s - clarithromycin - filmovertrukne tabletter - 500 mg
clarithromycin "krka" 250 mg filmovertrukne tabletter
krka d.d. novo mesto - clarithromycin - filmovertrukne tabletter - 250 mg
clarithromycin "stada" 250 mg filmovertrukne tabletter
stada arzneimittel ag - clarithromycin - filmovertrukne tabletter - 250 mg
clarithromycin "teva" 250 mg filmovertrukne tabletter
teva b.v. - clarithromycin - filmovertrukne tabletter - 250 mg
fluconazol "krka" 150 mg kapsler, hårde
krka sverige ab - fluconazol - kapsler, hårde - 150 mg
fluconazol "krka" 200 mg kapsler, hårde
krka sverige ab - fluconazol - kapsler, hårde - 200 mg
ritonavir "accord" 100 mg filmovertrukne tabletter
accord healthcare b.v. - ritonavir - filmovertrukne tabletter - 100 mg
biktarvy
gilead sciences ireland uc - bictegravir, emtricitabine, tenofovir alafenamide, fumarate - hiv infektioner - antivirale midler til systemisk anvendelse - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (se afsnit 5.
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudin, er tenofovir disoproxil fumarate - hiv infektioner - antivirale midler til behandling af hiv-infektioner, kombinationer - delstrigo er indiceret til behandling af voksne, som er smittet med hiv-1 uden tidligere eller nuværende bevis for modstand, nnrti klasse, lamivudin, eller tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.
pifeltro
merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.